Kaken Pharmaceutical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KKPCF research report →
About the company
Kaken Pharmaceutical Co. , Ltd. , a Tokyo-based company established in 1917, operates globally, specializing in the development, manufacture, and commercialization of a diverse array of medical products, medical devices, and agrochemicals.
- CEO
- Hiroyuki Horiuchi
- IPO
- 2020
- Employees
- 1,135
- HQ
- Tokyo, JP
Price Chart
- Market Cap
- $984.58M
- P/E
- 67.62
- P/S
- 1.88
- P/B
- 0.98
- EV/EBITDA
- 18.29
- Div Yield
- 4.97%
- Gross Margin
- 52.02%
- Op Margin
- -1.17%
- Net Margin
- 2.79%
- ROE
- 1.46%
- ROIC
- -0.52%
- Revenue
- $77.35B · -17.74%
- Net Income
- $2.16B · -84.53%
- EPS
- $57.52 · -84.26%
- Op Income
- $-904,658,701
- FCF YoY
- -155.79%
- 52W High
- $28.12
- 52W Low
- $22.30
- 50D MA
- $26.00
- 200D MA
- $25.60
- Beta
- 0.12
- Avg Volume
- 9.98
Get TickerSpark's AI analysis on KKPCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our KKPCF coverage
Recent articles, reports, and earnings notes.
No research on KKPCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KKPCF report →Similar companies
Peers in the same neighborhood.